The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Tue., May. 24, 9:17 AM

Slide #10. Evofem Biosciences, Inc. (NASDAQ:EVFM) 1 for 15 Reverse Split

Announced: 5/5/2022
Stock Split: 1 for 15
Record Date: 5/5/2022
Pay Date: 5/6/2022
EVFM Optionable?: Yes

Evofem Biosciences is a biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. Co. is utilizing its proprietary Multipurpose Vaginal pH Regulator (MVP-R™) platform to product candidates for several potential indications, including prevention of pregnancy and prevention of certain sexually transmitted infections. Co. is developing its primary MVP-R product candidate, Phexxi™, a non-hormonal, woman-controlled vaginal gel, for three potential indications: prevention of pregnancy, prevention of urogenital Chlamydia trachomatis infection and prevention of urogenital Neisseria gonorrhoeae infection.
EVFM Detailed Information Page & Split History »

Company Name: 
Evofem Biosciences Inc
Website: 
www.evofem.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding EVFM: 
4
Total Market Value Held by ETFs: 
$333.22M
Total Market Capitalization: 
$12.00M
% of Market Cap. Held by ETFs: 
2776.86%

Open the EVFM Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree EVFM Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.17 out of 4)
27th percentile
(ranked lower than approx. 73% of all stocks covered)

Analysts' Target Price:
EVFM Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.